Literature DB >> 29227722

Glucose phosphate isomerase (GPI) Tadikonda: Characterization of a novel Pro340Ser mutation.

Ahmar U Zaidi1, Prabhakar Kedar2, Prasad Rao Koduri3, Gerard W Goyette1, Steven Buck1, Donald E Paglia4, Yaddanapudi Ravindranath1.   

Abstract

After a thirty-year lag, we serendipitously reestablished contact with a patient with glucose phosphate isomerase deficiency and hydrops fetalis first reported in 1987. We now provide a clinical update and provide results of mutation analysis in this patient, from Southern India. The patient now an adult female of 36 years of age has moderate anemia but requires no transfusions except with some intercurrent illnesses. Exome sequencing studies showed a homozygous c.1018C>T (Pro340Ser) mutation in exon 12 of the glucose phosphate isomerase gene and later confirmed by direct sequencing. This mutation has not been previously described. To our knowledge, this is also the first known homozygous mutation in the hydrophobic core of the protein and is a highly deleterious mutation by in silico analysis and by clinical history in the family. Flow cytometry studies of band 3 content with eosin maleimide showed a unique tail of red cells on histograms, reflecting the dense red cells (presumably ATP depleted) seen on blood smears; similar findings were seen in patients with pyruvate kinase and phosphoglycerate kinase deficiency.

Entities:  

Keywords:  Glycolytic defects; hematology; red cells

Mesh:

Substances:

Year:  2017        PMID: 29227722     DOI: 10.1080/08880018.2017.1383541

Source DB:  PubMed          Journal:  Pediatr Hematol Oncol        ISSN: 0888-0018            Impact factor:   1.969


  3 in total

1.  Glucose Phosphate Isomerase Deficiency: High Prevalence of p.Arg347His Mutation in Indian Population Associated with Severe Hereditary Non-Spherocytic Hemolytic Anemia Coupled with Neurological Dysfunction.

Authors:  Prabhakar S Kedar; Rashmi Dongerdiye; Pooja Chilwirwar; Vinod Gupta; Ashish Chiddarwar; Rati Devendra; Prashant Warang; Harsha Prasada; Abhilasha Sampagar; Sunil Bhat; S Chandrakala; Manisha Madkaikar
Journal:  Indian J Pediatr       Date:  2019-04-27       Impact factor: 1.967

2.  Niche-Selective Inhibition of Pathogenic Th17 Cells by Targeting Metabolic Redundancy.

Authors:  Lin Wu; Kate E R Hollinshead; Yuhan Hao; Christy Au; Lina Kroehling; Charles Ng; Woan-Yu Lin; Dayi Li; Hernandez Moura Silva; Jong Shin; Juan J Lafaille; Richard Possemato; Michael E Pacold; Thales Papagiannakopoulos; Alec C Kimmelman; Rahul Satija; Dan R Littman
Journal:  Cell       Date:  2020-07-01       Impact factor: 41.582

3.  Oxidation Resistance 1 Modulates Glycolytic Pathways in the Cerebellum via an Interaction with Glucose-6-Phosphate Isomerase.

Authors:  Mattéa J Finelli; Teresa Paramo; Elisabete Pires; Brent J Ryan; Richard Wade-Martins; Philip C Biggin; James McCullagh; Peter L Oliver
Journal:  Mol Neurobiol       Date:  2018-06-15       Impact factor: 5.590

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.